Research Collaborations

Research Collaboration

 

Patient care is at the heart of everything we do at the Greenwood Genetic Center. The field of genetic and genomic medicine is advancing quickly with breakthroughs happening at an exciting pace. The Greenwood Genetic Center’s JC Self Research Institute of Human Genetics is leading the way in identifying the causes and mechanisms for autism, birth defects, intellectual disabilities and metabolic diseases.

Research collaboration is key to pool talent and resources for the sharing of discoveries, advancing of technologies and development of treatments for the good of our patients and their families. Advances in medicine occur faster when researchers, laboratory scientists and clinicians collaborate to learn more about genetic diseases. Scientists in the Research Division actively share information and discoveries with the other divisions at GGC as well as with researchers and clinical collaborators from around the world to help GGC reach its goal of reducing the prevalence and impact of genetic disorders.

Clemson Center for Human Genetics

GGC has joined efforts with the CCHG to expand the genomic capabilities of both Centers through the purchase of a NovaSeq instrument that will be used to sequence whole genomes. We actively collaborate with the CCHG on numerous research projects, including the use of fruit flies to model genetic disorders and test how natural variation in the genome can influence disease severity and penetrance.

University of South Carolina

GGC researchers have developed research collaborations with scientists at USC and USC School of Medicine. These interactions range from collaborative studies on autism and other neurodevelopmental disorders to the training of medical students during summer rotations.

Partnering with Pharmaceutical Companies

In light of our ultimate goal to identify treatments for genetic disorders, researchers at GGC engage in several partnerships with pharmaceutical companies to develop therapies. Dr. Luigi Boccuto is actively engaged in projects with a Swiss pharmaceutical company to identify new treatment strategies for autism and to classify patients with ASD into specific subgroups. He is also working with Circa Biosciences to develop a quick and reliable blood-based diagnostic test for ASD. Dr. Richard Steet is also working with pharmaceutical companies to explore new therapies for CDGs and lysosomal storage disorders.

 

Meet the Shorter Boys

Meet the Shorter Boys

Unexpected. If there is a term that sums up life it could very well be: unexpected. Life is full of unexpected moments. Some of these moments can be full of unexpected blessings while others may be full of unexpected obstacles. However, sometimes the unexpected can be both an obstacle and blessing at the same time; you just need someone to help you see both sides. The Greenwood Genetic Center is a place that helps shed some light on the...

In The News